How far are we from an approved drug for nonalcoholic steatohepatitis?
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2206953
Abstract: ABSTRACT Introduction Metabolic-associated fatty liver disease (MAFLD) previously known but still debatable, as nonalcoholic fatty liver disease (NAFLD) is one of the main causes of chronic liver disease and subsequent cirrhosis worldwide, accounting for around… read more here.
Keywords: disease; liver disease; mafld nafld; far approved ... See more keywords
Authors’ response to ‘Concordance of MAFLD and NAFLD diagnostic criteria in "real‐world" data’
Sign Up to like & getrecommendations! Published in 2020 at "Liver International"
DOI: 10.1111/liv.14656
Abstract: We thank Prof. Targer for his interest on our study1 . We totally agree with him on the concordance between MAFLD (metabolic dysfunction-associated fatty liver disease) and NAFLD (nonalcoholic fatty liver disease), at least among… read more here.
Keywords: concordance mafld; authors response; concordance; mafld nafld ... See more keywords
Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.968766
Abstract: Background/Purpose Metabolic associated fatty liver disease (MAFLD) was proposed as a new definition to put emphasis on the metabolic aspects of nonalcoholic fatty liver disease (NAFLD). We aim to compare the cardiovascular and renal burden… read more here.
Keywords: mafld nafld; ckd; patients mafld; risk ... See more keywords